Shareholders/Semperfi -
You seem to know a thing or to about a thing or two!
I believe in the future of MCET and feel it's just a matter of waiting now until all these clinical trials can be underway. Once approved, the company will be ranked up there with the mid-cap Nasdaq companies $5.00+ range in my opinion.
That being said, the biggest concern is the outstanding share structure. MultiCell is selling off hundreds of millions of shares a month and this is a big concern for anyone who is in this for the long-haul. What I would hate to see happen is just when everything comes together say 3-6+ months from now, Multicell announces a 10 for 1 RS as the O/S could be 4-5 Billion O/S by then if they keep diluting.
IF they have stopped the bleeding at 3.7B O/S there is hope MAYBE.
Not trying to be negative just keeping it real as there is no denying what's really taking place here to keep this operation going. The big question is, if MultiCell can get funding ASAP, they can stop the bleeding of the O/S, and if patents get approved soon enough we can be on our way to victory. Can it all be done on time without a R/S?
And not for nothing if MultiCell does get ample funding how about a stock buyback? To much to ask?
Thoughts?
News 
Market Data 
Discover 
AI
